Form 4 Tracker
John E Kao

Director, Chief Executive Officer · 14 filings · Latest: Sep 14, 2026

Alignment Healthcare, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ALHC
John E KaoDirector, Chief Executive OfficerSep 14, 2026
Sale
$13.0027,400$356.2K590,766
ALHC
John E KaoDirector, Chief Executive OfficerSep 11, 2026
Sale
$12.68385,270$4.9M1,223,473
ALHC
John E KaoDirector, Chief Executive OfficerSep 10, 2026
Sale
$12.96172,600$2.2M618,166
ALHC
JEK TRUST U/A DTD 02/08/2021—Sep 10, 2026
Proposed Sale
$13.03500,000$6.5M—
ALHC
John Kao—Sep 10, 2026
Proposed Sale
$13.06405,000$5.3M—
ALHC
John E KaoDirector, Chief Executive OfficerAug 10, 2026
Sale
$13.88298,000$4.1M790,766
ALHC
John E KaoDirector, Chief Executive OfficerJul 10, 2026
Sale
$19.86298,000$5.9M1,088,766
ALHC
JEK TRUST U/A DTD 02/08/2021—Jul 10, 2026
Proposed Sale
$21.03596,000$12.5M—
ALHC
John E KaoDirector, Chief Executive OfficerJun 10, 2026
Sale
$20.36298,000$6.1M1,386,766
ALHC
John E KaoDirector, Chief Executive OfficerMay 11, 2026
Sale
$16.89298,000$5.0M1,508,641
ALHC
JEK TRUST U/A DTD 02/08/2021—May 11, 2026
Proposed Sale
$17.93596,000$10.7M—
ALHC
John E KaoDirector, Chief Executive OfficerApr 13, 2026
Sale
$20.8082,299$1.7M1,806,641
ALHC
John E KaoDirector, Chief Executive OfficerApr 10, 2026
Sale
$20.63215,701$4.5M1,888,940
ALHC
John E KaoDirector, Chief Executive OfficerApr 7, 2026
Sale
$21.01250,000$5.3M2,104,641
ALHC
JEK TRUST U/A DTD 02/08/2021—Apr 7, 2026
Proposed Sale
$18.67548,000$10.2M—
ALHC
John E KaoDirector, Chief Executive OfficerMar 23, 2026
Sale
$17.48118,000$2.1M2,354,641
ALHC
JEK TRUST U/A DTD 02/08/2021—Mar 23, 2026
Proposed Sale
$17.34118,000$2.0M—
ALHC
John E KaoDirector, Chief Executive OfficerMar 18, 2026
Sale
$17.8473,046$1.3M1,784,868
ALHC
John Kao—Mar 18, 2026
Proposed Sale
$16.9980,788$1.4M—
ALHC
John E KaoDirector, Chief Executive OfficerMar 12, 2026
Sale
$17.4548,899$853.1K1,519,480

Page 1 of 2

Next →